Genesis Genetics has expanded its staff over the last year and is now moving to a bigger facility in downtown Plymouth to accommodate that growth.
The 13-year-old life sciences firm specializes in developing disease-detection technology that utilizes in vitro fertilization. Genesis Genetics has hired six people (laboratory scientists and administrative professionals) over the last year, expanding its staff to 40 employees, including 35 in Metro Detroit.
"We're growing pretty strongly," says Tony Gordon, managing director of
Genesis Genetics. "We're at 40-45 percent growth."
Genesis Genetics was based in Detroit before making the move to Plymouth. It also has a satellite lab in Phoenix. The new space in Plymouth is roughly double the size of its old home, which the company expects will help facilitate its growth. Gordon says the new facility will allow for faster turn around time for its research, easier access to Metro Airport and closer proximity to the University of Michigan.
"It's a little bit of all of those things," Gordon says.
Genesis Genetics’ has two primary fertility technologies: Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis. Preimplantation Genetic Screening is a technology where an embryo can be transferred in an in vitro fertilization cycle after being tested for chromosomal abnormalities. Preimplantation Genetic Diagnosis is a laboratory procedure that is used in conjunction with in vitro fertilization to help detect certain single-gene diseases.
The number of testing embryos Genesis Genetics uses for this technology has gone up considerably over the last year. It has processed more than 1,000 extra samples in 2013 and expects that number to continue to rise.
"We expect to keep growing," Gordon says.
Source: Tony Gordon, managing director of Genesis Genetics
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.